Neil Jones Sells 122,428 Shares of Huntsworth (HNT) Stock
Huntsworth (LON:HNT) insider Neil Jones sold 122,428 shares of Huntsworth stock in a transaction dated Thursday, April 19th. The shares were sold at an average price of GBX 97 ($1.39), for a total value of £118,755.16 ($170,038.89).
Neil Jones also recently made the following trade(s):
- On Monday, April 16th, Neil Jones purchased 144,590 shares of Huntsworth stock. The stock was acquired at an average price of GBX 97 ($1.39) per share, with a total value of £140,252.30 ($200,819.44).
HNT traded up GBX 1.40 ($0.02) during midday trading on Thursday, hitting GBX 98 ($1.40). The company’s stock had a trading volume of 363,527 shares, compared to its average volume of 1,010,000. Huntsworth has a 52-week low of GBX 40 ($0.57) and a 52-week high of GBX 95 ($1.36).
HNT has been the subject of several recent analyst reports. Peel Hunt restated a “buy” rating and issued a GBX 95 ($1.36) price target on shares of Huntsworth in a report on Wednesday, January 17th. Numis Securities restated a “buy” rating and issued a GBX 102 ($1.46) price target on shares of Huntsworth in a report on Wednesday, February 28th.
WARNING: This report was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this report on another domain, it was illegally copied and reposted in violation of US & international trademark & copyright legislation. The legal version of this report can be accessed at https://www.thecerbatgem.com/2018/04/19/neil-jones-sells-122428-shares-of-huntsworth-hnt-stock.html.
Huntsworth plc operates as a healthcare communications and public relations company in the United States, United Kingdom, rest of Europe, Asia, and the Middle East and Africa. It operates through four divisions: Huntsworth Health, Red Consultancy, Grayling, and Citigate Dewe Rogerson (CDR). The Huntsworth Health division offers an integrated suite of communications services for the science, health, and wellbeing industries.
Receive News & Ratings for Huntsworth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Huntsworth and related companies with MarketBeat.com's FREE daily email newsletter.